These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31301815)

  • 1. [Assessment for antihypertensive drug intake: How, where and when?].
    Bouhanick B; Fonquernie P; Bedue I; Schavgoulidze A; Gandia P
    Therapie; 2019 Dec; 74(6):651-664. PubMed ID: 31301815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment for antihypertensive drug intake in France in 2019 and adherence].
    Bouhanick B; Vaïsse B; Schavgoulidze A; Gandia P
    Presse Med; 2019 Dec; 48(12):1520-1526. PubMed ID: 31761608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of a risk calculator for drug compliance in treated hypertensives: The FLAHS Compliance Calculator].
    Girerd X; Hanon O; Pannier B; Vaïsse B
    Ann Cardiol Angeiol (Paris); 2017 Jun; 66(3):149-153. PubMed ID: 28554701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum concentration monitoring of antihypertensive drugs in treatment resistant hypertension].
    Edvardsen F; Øien CM; Helland A
    Tidsskr Nor Laegeforen; 2016 Oct; 136(18):1514-1515. PubMed ID: 27731592
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.
    Ritscher S; Georges C; Wunder C; Wallemacq P; Persu A; Toennes SW
    Blood Press; 2020 Oct; 29(5):291-298. PubMed ID: 32400211
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.
    Rabbia F; Fulcheri C; Di Monaco S; Covella M; Perlo E; Pappaccogli M; Veglio F
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):341-345. PubMed ID: 27160721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy.
    Ritscher S; Hoyer M; Georges C; Wunder C; Wallemacq P; Persu A; Obermüller N; Toennes SW
    PLoS One; 2020; 15(8):e0237383. PubMed ID: 32776967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers - drug classes with low adherence in antihypertensive therapy.
    Ritscher S; Hoyer M; Wunder C; Obermüller N; Toennes SW
    Sci Rep; 2019 Oct; 9(1):15652. PubMed ID: 31666620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Under pressure': The role of therapeutic drug monitoring in the treatment of hypertension.
    Versmissen J; van Steenkiste J; Koch BCP; Peeters LEJ
    Br J Clin Pharmacol; 2024 Aug; 90(8):1884-1891. PubMed ID: 38845455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.
    Eskås PA; Heimark S; Eek Mariampillai J; Larstorp AC; Fadl Elmula FE; Høieggen A
    Blood Press; 2016 Aug; 25(4):199-205. PubMed ID: 26729283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistant hypertension by unadvertised non-compliance detected by psychiatric expertise and drug dosages].
    Didier R; Gilard M; Denolle T
    Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):222-225. PubMed ID: 29753423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the EvalObs
    Girerd X; Hanon O; Vaïsse B
    Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):186-190. PubMed ID: 29786508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trends in the use of antihypertensive drugs in France from 2002 to 2012: FLAHS surveys].
    Girerd X; Hanon O; Pannier B; Vaïsse B; Mourad JJ
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):210-4. PubMed ID: 23759733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study.
    Wunder C; Persu A; Lengelé JP; Mg Georges C; Renkin J; Pasquet A; Carlier M; Zhang ZY; Staessen JA;
    Blood Press; 2019 Jun; 28(3):168-172. PubMed ID: 30942111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology].
    Denolle T; Chamontin B; Doll G; Fauvel JP; Girerd X; Herpin D; Vaïsse B; Villeneuve F; Halimi JM
    Presse Med; 2014 Dec; 43(12 Pt 1):1325-31. PubMed ID: 25459067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.
    Ceral J; Habrdova V; Vorisek V; Bima M; Pelouch R; Solar M
    Hypertens Res; 2011 Jan; 34(1):87-90. PubMed ID: 20882030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.